Repligen Corporation (RGEN)
USD 147.34
(-6.83%)
USD 147.34
(-6.83%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 711.8 Million USD | 68.29% |
| 2022 | 422.96 Million USD | 15.55% |
| 2021 | 366.05 Million USD | 32.91% |
| 2020 | 275.41 Million USD | 4.59% |
| 2019 | 263.31 Million USD | 154.44% |
| 2018 | 103.48 Million USD | 4.27% |
| 2017 | 99.25 Million USD | 4.18% |
| 2016 | 95.27 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 119.89 Thousand USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 4.6 Million USD | 0.0% |
| 1994 | 4.6 Million USD | 0.0% |
| 1993 | 4.6 Million USD | 70.37% |
| 1992 | 2.7 Million USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | -100.0% |
| 1989 | 100 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 737.73 Million USD | 3.64% |
| 2024 Q2 | 742.85 Million USD | 0.69% |
| 2023 Q3 | 419.88 Million USD | -0.7% |
| 2023 Q1 | 420.69 Million USD | -0.54% |
| 2023 Q2 | 422.84 Million USD | 0.51% |
| 2023 FY | 711.8 Million USD | 68.29% |
| 2023 Q4 | 711.8 Million USD | 69.52% |
| 2022 Q4 | 422.96 Million USD | 1.06% |
| 2022 Q3 | 418.51 Million USD | 0.44% |
| 2022 Q1 | 393.58 Million USD | 7.52% |
| 2022 FY | 422.96 Million USD | 15.55% |
| 2022 Q2 | 416.67 Million USD | 5.87% |
| 2021 FY | 366.05 Million USD | 32.91% |
| 2021 Q1 | 279.89 Million USD | 1.62% |
| 2021 Q2 | 305.98 Million USD | 9.32% |
| 2021 Q3 | 313.76 Million USD | 2.54% |
| 2021 Q4 | 366.05 Million USD | 16.67% |
| 2020 Q3 | 271.78 Million USD | 1.25% |
| 2020 Q2 | 268.41 Million USD | 0.82% |
| 2020 Q1 | 266.24 Million USD | 1.11% |
| 2020 FY | 275.41 Million USD | 4.59% |
| 2020 Q4 | 275.41 Million USD | 1.34% |
| 2019 FY | 263.31 Million USD | 154.44% |
| 2019 Q4 | 263.31 Million USD | 1.56% |
| 2019 Q2 | 129.2 Million USD | 3.54% |
| 2019 Q1 | 124.78 Million USD | 20.58% |
| 2019 Q3 | 259.28 Million USD | 100.68% |
| 2018 Q3 | 102.4 Million USD | 1.06% |
| 2018 Q1 | 100.27 Million USD | 1.03% |
| 2018 FY | 103.48 Million USD | 4.27% |
| 2018 Q4 | 103.48 Million USD | 1.06% |
| 2018 Q2 | 101.32 Million USD | 1.05% |
| 2017 Q2 | 97.22 Million USD | 1.02% |
| 2017 Q1 | 96.24 Million USD | 1.02% |
| 2017 Q4 | 99.25 Million USD | 1.04% |
| 2017 FY | 99.25 Million USD | 4.18% |
| 2017 Q3 | 98.23 Million USD | 1.03% |
| 2016 Q3 | 94.31 Million USD | 1.0% |
| 2016 FY | 95.27 Million USD | 0.0% |
| 2016 Q4 | 95.27 Million USD | 1.01% |
| 2016 Q2 | 93.38 Million USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | -100.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 Q2 | 120.37 Thousand USD | 0.4% |
| 2005 FY | 119.89 Thousand USD | 0.0% |
| 2005 Q1 | 119.89 Thousand USD | 0.0% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 261.6 Thousand USD | 117.32% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 Q1 | 4.6 Million USD | 0.0% |
| 1995 Q2 | - USD | -100.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 Q3 | - USD | 0.0% |
| 1995 FY | 4.6 Million USD | 0.0% |
| 1994 FY | 4.6 Million USD | 0.0% |
| 1994 Q3 | 4.6 Million USD | 0.0% |
| 1994 Q4 | 4.6 Million USD | 0.0% |
| 1994 Q1 | 4.6 Million USD | -4.17% |
| 1994 Q2 | 4.6 Million USD | 0.0% |
| 1993 Q1 | 4.6 Million USD | 0.0% |
| 1993 Q2 | 4.6 Million USD | 0.0% |
| 1993 Q3 | 4.6 Million USD | 0.0% |
| 1993 FY | 4.6 Million USD | 70.37% |
| 1993 Q4 | 4.8 Million USD | 4.35% |
| 1992 Q3 | - USD | 0.0% |
| 1992 FY | 2.7 Million USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 Q1 | 2.7 Million USD | 0.0% |
| 1992 Q2 | - USD | -100.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 FY | - USD | -100.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q4 | - USD | -100.0% |
| 1990 Q3 | 2.1 Million USD | 0.0% |
| 1989 Q1 | 100 Thousand USD | 0.0% |
| 1989 FY | 100 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 85.7 Million USD | -730.518% |
| AngioDynamics, Inc. | 5.91 Million USD | -11935.915% |
| AtriCure, Inc. | 74.49 Million USD | -855.519% |
| Avinger, Inc. | 15.39 Million USD | -4523.605% |
| Azenta, Inc. | 60.43 Million USD | -1077.781% |
| BioLife Solutions, Inc. | 42.69 Million USD | -1567.34% |
| The Cooper Companies, Inc. | 2.56 Billion USD | 72.295% |
| Daxor Corporation | 755.65 Thousand USD | -94096.456% |
| Ekso Bionics Holdings, Inc. | 7.16 Million USD | -9830.301% |
| Femasys Inc. | 6.7 Million USD | -10522.542% |
| GlucoTrack, Inc. | 196 Thousand USD | -363065.306% |
| Harvard Bioscience, Inc. | 42.77 Million USD | -1564.143% |
| Hologic, Inc. | 2.53 Billion USD | 71.917% |
| ICU Medical, Inc. | 1.7 Billion USD | 58.245% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -692.655% |
| KORU Medical Systems, Inc. | 4.44 Million USD | -15913.156% |
| LeMaitre Vascular, Inc. | 19.09 Million USD | -3627.698% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 970 Million USD | 26.618% |
| Microbot Medical Inc. | 231 Thousand USD | -308040.26% |
| Meihua International Medical Technologies Co., Ltd. | 7.33 Million USD | -9609.33% |
| Merit Medical Systems, Inc. | 891.35 Million USD | 20.144% |
| Nephros, Inc. | 1.83 Million USD | -38669.281% |
| NovoCure Limited | 596.24 Million USD | -19.382% |
| NEXGEL, Inc. | 2.79 Million USD | -25339.743% |
| NEXGEL, Inc. | 2.79 Million USD | -25339.743% |
| Singular Genomics Systems, Inc. | 75.28 Million USD | -845.442% |
| OraSure Technologies, Inc. | 13.5 Million USD | -5171.06% |
| Pro-Dex, Inc. | 13.54 Million USD | -5154.329% |
| Pulse Biosciences, Inc. | 9.14 Million USD | -7684.383% |
| Predictive Oncology Inc. | 2.85 Million USD | -24816.008% |
| Precision Optics Corporation, Inc. | 3.43 Million USD | -20625.348% |
| QuidelOrtho Corporation | 2.61 Billion USD | 72.771% |
| Sanara MedTech Inc. | 11.79 Million USD | -5936.273% |
| STAAR Surgical Company | 35.83 Million USD | -1886.393% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 342 Thousand USD | -208029.825% |
| DENTSPLY SIRONA Inc. | 2.29 Billion USD | 69.039% |
| Jin Medical International Ltd. | 4.11 Million USD | -17206.2% |